⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

April 9, 2024Neurology

Predictive Utility of Serum Protein Biomarkers from the Octave MSDA Panel for Optic Neuritis Events in People with Multiple Sclerosis (S42.008)

Kian Jalaleddini Dejan Jakimovski Anisha Keshavan Shannon R. McCurdy Ferhan Qureshi Ati Ghoreyshi Niels Bergsland Michael G. Dwyer Murali Ramanathan Bianca Weinstock‐Guttman Ralph H. B. Benedict Robert Zivadinov

View Full Paper

Ask AI

Bookmark

Share

Abstract

To assess the predictive power of serum protein biomarkers measured from the Octave Multiple Sclerosis Disease Activity (MSDA) immunoassay panel for predicting optic neuritis (ON) events in people with MS (pwMS) using machine learning models.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Jalaleddini et al. (2024) studied this question.

synapsesocial.com/papers/68e6fdb8b6db64358767807f https://doi.org/10.1212/wnl.0000000000204768

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Blood‐based inflammatory protein biomarker panel for the prediction of relapse and severity in patients with neuromyelitis optica spectrum disorder: A prospective cohort study2024 · 7 citations
2Association between serum multi-protein biomarker profile and real-world disability in multiple sclerosiscross-sectional · 2023 · 17 citations
3Prognostic Biomarker Signature of Relapse in Neuromyelitis Optica Spectrum Disorders in the CIRCLES Observational StudyCohort Study · 2026
4Real-world Utilization of a Novel Multi-analyte Blood-based Biomarker Panel, the Octave® Multiple Sclerosis Disease Activity (MSDA) Test in Clinical Practice Across the United States (S8.010)Original Research · 2026
5Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect clinical and radiographic disease activity in multiple sclerosis2024 · 38 citations